Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Baihui Biotechnology is a medical technology company headquartered in Beijing, China, specializing in the field of in vitro diagnostics (IVD). The company focuses on the research, development, and production of Point-of-Care Testing (POCT) reagents and automated diagnostic instruments. Its product portfolio includes a wide range of rapid tests for infectious diseases, cardiovascular markers, inflammatory indicators, and hormonal health. Utilizing core technologies such as fluorescence immunochromatography and colloidal gold, Beijing Baihui provides healthcare professionals with rapid and reliable diagnostic tools for clinical decision-making. The company is recognized as a national high-tech enterprise and maintains quality standards such as ISO 13485 to support its domestic and international operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Baihui Biotechnology.